Transplantation and Aging

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 9, 2006, Pages 893-898

  Deeg, H Joachim ^a   Friedman, Debra ^a   Bohr, Vilhelm A ^b   Constine, Louis ^c   Jones, Irene M ^d   Sigurdson, Alice ^e   Socié, Gérard ^f   Van Zant, Gary ^g   Wei, Qingyi ^h   Martin, Paul ^a  

^a USA   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f SAINT LOUIS HOSPITAL   (France)

^g UNIVERSITY OF KENTUCKY   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aging; Epidemiology; Hematopoietic cell transplantation; Molecular mechanisms; Radiation biology; Stem cell physiology

Indexed keywords

DNA TOPOISOMERASE INHIBITOR; EPOXIDE HYDROLASE; FLUDARABINE; GYRASE INHIBITOR; MICROSOME ENZYME; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; SINGLE STRANDED DNA; WERNER SYNDROME PROTEIN;

AGED; AGING; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTHRALGIA; ATOMIC BOMB SURVIVOR; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BASAL CELL CARCINOMA; BLOOM SYNDROME; BRAIN CANCER; BREAST CARCINOMA; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL POPULATION; COLON CANCER; DNA REPAIR; DNA STRAND BREAKAGE; DYSPNEA; EXCISION REPAIR; FATIGUE; GENETIC SUSCEPTIBILITY; HAIR LOSS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; LUNG DISEASE; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MUSCLE CRAMP; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MUTATIONAL ANALYSIS; NONHODGKIN LYMPHOMA; NONHUMAN; NUCLEAR ACCIDENT; OUTCOMES RESEARCH; RADIATION EXPOSURE; RADIATION INJURY; REVIEW; SECOND CANCER; SEXUAL DYSFUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STEM CELL MOBILIZATION; THYROID CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; VIRUS PATHOGENESIS; WERNER SYNDROME; WHOLE BODY RADIATION; XENOBIOTIC METABOLISM;

AGING; AGING, PREMATURE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE;

EID: 33747361061     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.04.003     Document Type: Review

References (44)

1. Syrjala K.L., Langer S.L., Abrams J.R., Storer B.E., and Martin P.J. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 23 (2005) 6596-6606
2. Syrjala K.L., Langer S., Abrams J., Storer B., and Martin P. Physical and mental recovery after hematopoietic stem cell transplantation. Discov Med 4 (2004) 263-269
3. Bhatia S., Robison L.L., Francisco L., et al. Late mortality in survivors of autologous hematopoietic-cell transplantation. report from the Bone Marrow Transplant Survivor Study. Blood 105 (2005) 4215-4222
4. Campisi J. Senescent cells, tumor suppression, and organismal aging. good citizens, bad neighbors. [review]. Cell 120 (2005) 513-522
5. McBride W.H., Chiang C.S., Olson J.L., et al. A sense of danger from radiation. [review]. Radiat Res 162 (2004) 1-19
6. Van Zant G., and Liang Y. The role of stem cells in aging. [review]. Exp Hematol 31 (2003) 659-672
7. Geiger H., and Van Zant G. The aging of lympho-hematopoietic stem cells. [review]. Nat Immunol 3 (2002) 329-333
8. Geiger H., True J.M., de Haan G., and Van Zant G. Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy. Blood 98 (2001) 2966-2972
9. Lee J.W., Harrigan J., Opresko P.L., and Bohr V.A. Pathways and functions of the Werner syndrome protein. [review]. Mech Ageing Dev 126 (2005) 79-86
10. Harrigan J.A., Wilson III D.M., Prasad R., et al. The Werner syndrome protein operates in base excision repair and cooperates with DNA polymerase beta. Nucleic Acids Res 34 (2006) 745-754
11. Opresko P.L., Mason P.A., Podell E.R., et al. POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates. J Biol Chem 280 (2005) 32069-32080
12. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., and Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 160 (2003) 381-407
13. Thompson D.E., Mabuchi K., Ron E., et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. [review]. Radiat Res 137 suppl 2 (1994) S17-S67
14. Sigurdson A.J., Ronckers C.M., Mertens A.C., et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study). a nested case-control study. Lancet 365 (2005) 2014-2023
15. Yamada M., Wong F.L., Fujiwara S., Akahoshi M., and Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res 161 (2004) 622-632
16. Nakashima E., Fujiwara S., and Funamoto S. Effect of radiation dose on the height of atomic bomb survivors. a longitudinal study. Radiat Res 158 (2002) 346-351
17. Neriishi K., Nakashima E., and Delongchamp R.R. Persistent subclinical inflammation among A-bomb survivors. Int J Radiat Biol 77 (2001) 475-482
18. Hauptmann M., Mohan A.K., Doody M.M., Linet M.S., and Mabuchi K. Mortality from diseases of the circulatory system in radiologic technologists in the United States. Am J Epidemiol 157 (2003) 239-248
19. Mohan A.K., Hauptmann M., Linet M.S., et al. Breast cancer mortality among female radiologic technologists in the United States. J Natl Cancer Inst 94 (2002) 943-948
20. Cleaver J.E. Cancer in xeroderma pigmentosum and related disorders of DNA repair. [review]. Nat Rev Cancer 5 (2005) 564-573
21. Qiao Y., Spitz M.R., Guo Z., et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res 509 (2002) 165-174
22. Wei Q., Lee J.E., Gershenwald J.E., et al. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 95 (2003) 308-315
23. Moriwaki S., Ray S., Tarone R.E., Kraemer K.H., and Grossman L. The effect of donor age on the processing of UV-damaged DNA by cultured human cells. reduced DNA repair capacity and increased DNA mutability. Mutat Res 364 (1996) 117-123
24. Neumann A.S., Sturgis E.M., and Wei Q. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers. a review of molecular epidemiological studies. Mol Carcinog 42 (2005) 65-92
25. Wei Q., Cheng L., Amos C.I., et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk. a molecular epidemiologic study. J Natl Cancer Inst 92 (2000) 1764-1772
26. Bosken C.H., Wei Q., Amos C.I., and Spitz M.R. An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J Natl Cancer Inst 94 (2002) 1091-1099
27. Jones I.M., Moore D.H., Thomas C.B., Thompson C.L., Strout C.L., and Burkhart-Schultz K. Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 2 (1993) 249-260
28. Jones I.M., Galick H., Kato P., et al. Three somatic genetic biomarkers and covariates in radiation-exposed Russian cleanup workers of the Chernobyl nuclear reactor 6-13 years after exposure. Radiat Res 158 (2002) 424-442
29. Deschavanne P.J., Debieu D., Fertil B., and Malaise E.P. Re-evaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins. [published correction appears in Int J Radiat Biol Relat Stud Phys Chem Med. 1986;50:1129]. Int J Radiat Biol Relat Stud Phys Chem Med 50 (1986) 279-293
30. Mohrenweiser H.W., Wilson III D.M., and Jones I.M. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. [review]. Mutat Res 526 (2003) 93-125
31. Xi T., Jones I.M., and Mohrenweiser H.W. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 83 (2004) 970-979
32. Sigurdson A.J., Hauptmann M., Alexander B.H., et al. DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutat Res 586 (2005) 173-188
33. Jones I.M., Thomas C.B., Xi T., Mohrenweiser H.W., and Nelson D.O. Analyzing relationships between complex genotypes and repair of DNA damage identifies functionally important variants. Am Assoc Cancer Res 45 (2004) 341 Abstract 1484
34. Curtis R.E., Metayer C., Rizzo J.D., et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation. an international case-control study. Blood 105 (2005) 3802-3811
35. Kolb H.J., Socie G., Duell T., et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med 131 (1999) 738-744
36. Friedman D.L., Leisenring W., Schwartz J., and Deeg H.J. Is the risk of breast cancer increased after hematopoietic cell transplantation?. Blood 104 pt 1 (2004) 19a-20a Abstract 55
37. Deeg H.J., and Socié G. Malignancies after hematopoietic stem cell transplantation. many questions, some answers. Blood 91 (1998) 1833-1844
38. Friedman D.L., Leisenring W., Schwartz J.L., and Deeg H.J. Second malignant neoplasms following hematopoietic stem cell transplantation. Int J Hematol 79 (2004) 229-234
39. Leisenring W., Friedman D.L., Flowers M.E.D., Schwartz J.L., and Deeg H.J. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol 24 (2006) 1119-1126
40. Haase D., Binder C., Bunger J., et al. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 26 (2002) 249-254
41. Mertens A.C., Mitby P.A., Radloff G., et al. XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer 101 (2004) 1463-1472
42. Krajinovic M., Labuda D., Richer C., Karimi S., and Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia. influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 93 (1999) 1496-1501
43. Woo M.H., Shuster J.J., Chen C., et al. Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies. Leukemia 14 (2000) 232-237
44. Allan J.M., Wild C.P., Rollinson S., et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. [published correction appears in Proc Natl Acad Sci USA. 2001;98:15394]. Proc Natl Acad Sci USA 98 (2001) 11592-11597